// App-Quantinova.ai

TCT-16 : Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 5-Year Clinical and Imaging Results

Researchers

Presenter

  • Stefan Verheye

Principal Investigators

  • Joachim Schofer

  • Michael Maeng

  • Carsten Skurk

  • Roberto Botelho

  • J. Ribamar Costa Jr.

  • Daniel Chamie

  • Juliana Castro

  • Andrea Abizaid

  • John Yan

  • Lynn Morrison

  • Vinayak Bhat

  • Sara Toyloy

  • Alexandre Abizaid

Medical Centers

  • Department of Cardiology, Charite medical University, Campus Benjamin Franklin, Berlin, Berlin, Germany

  • Aarhus University Hospital, Aarhus, Denmark

  • Instituto Dante Pazzanese, Sao Paulo, São Paulo, Brazil

  • Elixir Medical, sunnyvale, California, United States

  • Cardiovascular Center ZNA Middelheim, Antwerp, Belgium

  • Triangulo Heart Institute, Uberlândia, Minas Gerais, Brazil

  • CRC, São Paulo, São Paulo, Brazil

  • Medical Care Center Prof. Mathey, Prof. Schofer and Albertinen Heart Center, Hamburg, Hamburg, Germany

Locations

  • Germany

  • Denmark

  • Brazil

  • United States

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • Serine/threonine-protein kinase mTOR

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved